Clinical Trials Week

Susan Hasty, Publisher

Table of Contents . . . March 10th, 2008

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Clinical Trials Week | Other Publications

Allergies - Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology

Clinical Research - Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research

Clinical Trial Research - Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte

Evotec Ag - Evotec Starts Phase II in Smoking Cessation with EVT 302

Glioblastoma - Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study

Obesity and Diabetes - Reports from M.A. Kim et al highlight recent research in obesity and diabetes

Cancer Therapy - Studies from Georgetown University further understanding of cancer therapy

Clinical Trial Research - Scientists at University of Strathclyde describe research in clinical trial research

Enzyme Research - Studies from Institute of Molecular and Cell Biology yield new data on enzyme research

Life Sciences - New pediatric in children data have been reported by scientists at University of North Carolina, Department of Pediatrics

Bipolar Disorder - Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)

Cancer - Keynote Lecture on Hyperthermia Therapy Receives Standing Ovation at Biannual Meeting of the German Cancer Society

Cancer - NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference

Cancer - Treatment of First Patient in Phase I Clinical Trial of Bionomics' Anti-Cancer Drug BNC105

Clinical Trial Research - Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients

Diabetes - Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers

Fibroids - Repros' IND for the Commencement of Phase III Studies of Proellex(R) in the Treatment of Anemia Associated with Uterine Fibroids is Now Effective

Heart Attack - Prochymal(TM) Demonstrates Lasting Benefit in Heart Attack Patients; Osiris Receives FDA Clearance to Start Phase II Trial

Hepatic Encephalopathy - Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy

Hepatitis B Virus - Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil

Hepatitis C Virus - Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress

HIV/AIDS - GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials

InSite Vision Incorporated - InSite Vision Reports Fourth Quarter and Full Year 2007 Financial Results

La Jolla Pharmaceutical Company - La Jolla Pharmaceutical Company Reports Fourth Quarter and Year-End Financial Results

Lung Cancer - Oncothyreon's PX-478 is effective in preclinical model of human lung cancer

Non-Small Cell Lung Cancer - Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting

Ocera Therapeutics, Inc. - M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer

Pharmacokinetics - Javelin Pharmaceuticals Completes Subject Accrual for all Pharmacokinetic Clinical Studies of PMI-150

Pharmacology - PRA International to Open Expanded Clinical Pharmacology Center

Pharmos Corporation - Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results

Savient Pharmaceuticals, Inc. - Savient Provides Further Information on Top Line Phase 3 Trials Results for Puricase(R) (pegloticase)

Solid Cancer - Ambit Biosciences Announces the Formation of Two Clinical Advisory Boards

Type 2 Diabetes - Metabasis Therapeutics Completes Enrollment of Its Proof-of-Concept Clinical Trial for MB07803, Its Product Candidate for the Treatment of Type 2 Diabetes

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Top Medical Newsletters

Awards

eHealthcare Leadership 2011 Winner

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx on Facebook

Home | About | Medical Topics | Products | Contact | Privacy Policy